Mission Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mission Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10671
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, neurodegeneration, inflammation and others. the company uses its proprietaryDUB platform to generate small-molecule drug candidates that have clinical and commercial potential.The company receives grants to support the discovery and preclinical development of inhibitors directed against a specific DUB. It operates research facility in Cambridge. Mission is headquartered in Cambridge, the UK.

Mission Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Mission Therapeutics Raises USD85.7 Million in Financing Round 10
Mission Therapeutics Raises US$32 Million In Series B Financing 12
Partnerships 13
Mission Therapeutics and AbbVie Enter into Collaboration Agreement 13
ChemOvation Enters Into Drug Discovery Agreement With Mission Therapeutics 14
Mission Therapeutics Ltd – Key Competitors 15
Mission Therapeutics Ltd – Key Employees 16
Mission Therapeutics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Sep 04, 2018: Mission Therapeutics strengthens clinical development team with appointment of Dr Judit Molnar as senior director, translational medicine 18
Mar 08, 2018: Mission Therapeutics Appoints Dr Bobby Soni to its Board of Directors 19
Jun 27, 2017: Mission Therapeutics Appoints Scientific Advisory Board 20
Mar 20, 2017: Mission Therapeutics Appoints Dr Anne Phelan as Senior Vice President, Head of Discovery Research 21
Government and Public Interest 22
Apr 11, 2018: Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation 22
Sep 29, 2017: Mission Therapeutics’ Scientists Highlight Significance of Deubiquitylating Enzymes as Key Drug Targets 23
Product News 24
04/11/2017: Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mission Therapeutics Raises USD85.7 Million in Financing Round 10
Mission Therapeutics Raises US$32 Million In Series B Financing 12
Mission Therapeutics and AbbVie Enter into Collaboration Agreement 13
ChemOvation Enters Into Drug Discovery Agreement With Mission Therapeutics 14
Mission Therapeutics Ltd, Key Competitors 15
Mission Therapeutics Ltd, Key Employees 16
Mission Therapeutics Ltd, Other Locations 17

List of Figures
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mission Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Turkiye IS Bankasi A.S.:戦略・SWOT・企業財務分析
    Turkiye IS Bankasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Turkiye IS Bankasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nanosonics Ltd (NAN)-医療機器分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Makedonijaturist AD Skopje:企業の戦略・SWOT・財務情報
    Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Probiogen AG:企業のM&A・事業提携・投資動向
    Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Probiogen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Astellas Pharma Inc (4503):企業の財務・戦略的SWOT分析
    Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NuStar Energy L.P.:企業の戦略・SWOT・財務分析
    NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report Summary NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EDF Renewable Energy Inc:電力:M&Aディール及び事業提携情報
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. It designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It develops …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Double Eagle Development LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Double Eagle Development LLC (DED) is an oil and gas company exploration and production company. The company carries out the business of crude oil and natural gas exploration, development and production through horizontal and vertical operations in the Midland Basin of West Texas. It also ac …
  • Vallourec Sa:企業の戦略・SWOT・財務分析
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ind-Swift Ltd (INDSWFTLTD):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Ltd (Ind-Swift), is a pharmaceutical company that develops, manufactures and markets finished goods dosage, active pharmaceutical ingredients and herbal products. The company offers products such as dispersible tablets, sustained release tablets, mouth dissolving tablets, chewable …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Chemical Company of Malaysia Bhd (CCM):企業の財務・戦略的SWOT分析
    Chemical Company of Malaysia Bhd (CCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Mizuno Corp (8022):企業の財務・戦略的SWOT分析
    Mizuno Corp (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Alcazar Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company that acquires, develops and operates power generation projects using solar photovoltaic (PV) and onshore wind technologies. The company offers services such as business development, asset management, investment and financing, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆